Clinical trial
Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in…
NCT00377468 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00377468 |
|---|---|
| Title | Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) |
| Official title | Low Dose Administration of Delta9-Tetrahydrocannabinol for the Prevention of Hyperalgesia and Chronic Pain in Patients With Acute Complex Regional Pain Syndrome (CRPS) of the Upper Limb |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | German Federal Ministry of Education and Research German Research Network on Neuropathic Pain |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Complex Regional Pain Syndromes, CRPS |
| Intervention type | Drug |
| Interventions | Delta9-Tetrahydrocannabinol |
| Enrollment | 100 |
| Start date | Sep 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Sep 18, 2006 |
| Last update posted | Jun 30, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: